Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment

##article.authors##

  • Madiha Mehmood Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan
  • Muhammad Anees Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan

##semicolon##

https://doi.org/10.53778/pjkd92302

##semicolon##

acute kidney injury##common.commaListSeparator## anti tuberculous treatment##common.commaListSeparator## ATT##common.commaListSeparator## Rifampicin##common.commaListSeparator## Isoniazid##common.commaListSeparator## AKI

##article.abstract##

Although life-saving, anti-tuberculosis therapy (ATT) carries the risk of acute kidney injury (AKI), potentially complicating its management.

 

Methods: 102 subjects starting on ATT were followed for 2 months. Presence of AKI was documented with monitoring of kidney functions.

Results:

AKI was observed among 14.7% patients, predominantly affecting middle-aged males.

Conclusion:

Early recognition of AKI by monitoring for kidney function is crucial for reducing the risk of long-term sequelae of kidney failure among patients taking ATT.

##submission.downloads##

##submissions.published##

2025-06-30

##issue.issue##

##section.section##

Original Article